INGALLS & SNYDER LLC

Position in GMAB — Genmab A/S

CIK 1041885 NEW YORK, NY

Position in GMAB

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,955,665

-$295,969 QoQ

Shares Held

72,891

-0.3% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 1.5639790920689796.ToString("F0")% Shared 0.ToString("F0")% None 98.43602090793102.ToString("F0")%

Healthcare · as of Mar 31, 2026

INGALLS & SNYDER LLC holds $352,579,823 across 11 Biotechnology names. GMAB ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	7,608,716	$306,707,341
2	OMER	Omeros Corp	3,559,423	$37,587,506
3	HYFT	MindWalk Holdings Corp.	2,907,040	$3,284,955
4	GMAB	Genmab A/S This page	72,891	$1,955,665
5	VRTX	Vertex Pharmaceuticals Inc / Ma	3,012	$1,344,978
6	EPRX	Eupraxia Pharmaceuticals Inc.	75,650	$547,706
7	HALO	Halozyme Therapeutics, Inc.	7,339	$474,319
8	VCEL	Vericel Corp	14,200	$456,814

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,955,665	72,891	-0.3%	Shares	Other	2026-05-13
2025-12-31	$2,251,634	73,105	-31.9%	Shares	Other	2026-02-13
2025-09-30	$3,290,093	107,274	-10.2%	Shares	Other	2025-11-07
2025-06-30	$2,468,539	119,484	-20.0%	Shares	Other	2025-07-31
2025-03-31	$2,923,587	149,315	+9.7%	Shares	Other	2025-05-12
2024-12-31	$2,839,551	136,059	-37.7%	Shares	Other	2025-01-29
2024-09-30	$5,326,615	218,483	-4.9%	Shares	Other	2024-11-14
2024-06-30	$5,772,361	229,700	+29.3%	Shares	Other	2024-07-31
2024-03-31	$5,311,507	177,583	—	Shares	Other	2024-05-13
No filing history on record for this holder in this stock.